Elsevier

Surgical Clinics of North America

Volume 80, Issue 6, 1 December 2000, Pages 1683-1693
Surgical Clinics of North America

MELANOMA METASTASES THROUGH THE LYMPHATIC SYSTEM

https://doi.org/10.1016/S0039-6109(05)70255-3Get rights and content

Many patients with cancer, including those with cutaneous malignant melanoma, can be treated to cure if their tumor is surgically excised early in its evolution, at which point the tumor is confined to its site of origin. Management becomes more difficult as tumor cells detach from the primary tumor mass and metastasize to sites in the body that are remote from their point of origin. All forms of metastasis increase the problems of patient management and the likelihood that a patient will die from the effects of their cancer. There is, however, an important hierarchy of risk associated with cancer spread by different routes and to different organs.31 Because the problems associated with spread through the circulatory system to visceral sites remain so intractable, most research has focused on determining the mechanisms of this type of metastatic extension. Less attention has been paid to spread from the primary tumor through the lymphatics to the regional lymph nodes. Some investigators regard the regional nodes as merely way stations en route to the blood stream and the vital organs, and consider that treatment of the nodes is unlikely to influence the final outcome. Others regard this view as negative and believe that timely and complete removal of tumor metastases, especially in the early phase of nodal metastasis to the regional nodes, can interrupt the sequence of events that eventually leads to visceral metastases and death. Involvement of the regional nodes by metastatic melanoma certainly is a serious event, and approximately 50% of patients in whom this occurs die of melanoma within 5 years. On the other hand, most patients who remain tumor-free 5 years after lymphadenectomy achieve long-term tumor-free survival.2 This contrasts sharply with the fate of patients who develop visceral metastases, most of whom die from disseminated melanomatosis within months or a few years. The difference in outcome between these two groups indicates that they represent different stages in disease evolution or variants of melanoma pathobiology. There is a clear incentive to do whatever is possible to prevent the evolution of melanoma to or beyond the stage of nodal involvement.

The need to reappraise the significance of the lymph nodes' regional role in cancer is suggested by recent data from a variety of sources. Increased understanding of lymph node function and pathobiology has come from studies showing that each lymph node functions as a separate organ.10 It has also been shown that the lymph node(s) located closest to a primary tumor, on the direct lymphatic pathway from primary to regional nodal group, the sentinel node(s), often are reliably and exclusively the site of earliest metastases.9, 24 The author and others have demonstrated that the regional lymph nodes located nearest to a primary tumor are dysfunctional.8, 16, 23 Tumor-proximate lymph nodes show profound alterations in the distribution and phenotype of lymphoid and other cells, especially in the T-dependent paracortical areas.6, 8, 12 These modifications of lymph node structure and function are most likely caused by mediators released by the tumor.10 Recent studies focusing on the sentinel nodes from melanoma and breast cancer patients have shown that the nodes most exposed to tumor influence are significantly more modulated than adjacent, non-sentinel nodes.7, 17

The relationship of tumor-induced suppression of lymph node function and an environment in the sentinel nodes that is conducive to the survival and expansion of metastatic tumor cells probably is critical to tumor progression. This may represent the last stage of tumor evolution that is susceptible to therapeutic intervention to prevent or reverse the progress of tumor cells toward dissemination. Although present intervention is primarily surgical, an understanding of the mechanisms of nodal dysfunction may lead to medical therapies to reverse the process and reduce nodal susceptibility to tumor spread.

Section snippets

ROLE OF LYMPH NODE METASTASES IN TUMOR BIOLOGY

Most melanoma patients who develop metastatic spread first develop tumor in the ipsilateral regional lymph nodes. The path of spread is predictable for tumors on the limbs, although tumors occasionally spread first to the popliteal or antecubital nodes rather than to the more usual inguinal or axillary node groups. Drainage from primary melanomas in the head and neck area is less straightforward, and spread to the posterior cervical nodes or across the midline is frequently encountered. Primary

EVALUATION OF THE REGIONAL NODES IN THE ASSESSMENT OF PROGNOSIS

The prognosis for patients with melanoma spread to the regional nodes is worse than that of individuals with melanoma confined to the primary site.5 The amount of tumor present in the nodes and the likely outcome are clearly related. Tumor burden is estimated most easily by identifying the number of nodes that contain melanoma relative to the total number of nodes removed.2, 31 A combination of the number of tumor-positive nodes and the proportion of total lymph node mass that is occupied by

HANDLING AND PATHOLOGIC ANALYSIS OF LYMPH NODES

The effectiveness of the pathologic lymph node analysis is affected by the manner in which lymph node tissues are excised and preserved, and the timeliness with which they are transferred to the pathology laboratory. Surgeons should minimize “crush artefact” and excessive distortion by cautery, and should make sure that specimens are placed immediately after excision in a sufficient quantity of formalin. The most frequent contributions from pathology are analysis of fine needle aspirates, the

DIFFICULTIES IN DIAGNOSIS OF NODAL METASTATIC MELANOMA

Identification and diagnosis are more difficult if a melanoma is amelanotic, if the node contains benign nevocyte aggregates, and in the absence of clinical or historical evidence of a primary melanoma (unknown primary).

SELECTIVE LYMPH NODE DISSECTION

The author discourages the use of frozen sections in the interpretation of sentinel nodes because identification of small numbers of melanoma cells is more accurate in well-fixed and stained sections. Additionally, critical diagnostic tissue is lost during “facing up” of the frozen block and subsequent preparation of the fixed material. The distortion of tissues melted from a frozen block and subsequently fixed requires removal of substantial tissue to achieve a “full-face” section from the

References (33)

  • S.W. McCarthy et al.

    Naevus cells in lymph nodes

    Pathology

    (1974)
  • V.J. McGovern

    Spontaneous regression of melanoma

    Pathology

    (1975)
  • S.E. Singletary et al.

    Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma

    Am J Surg

    (1986)
  • M.E. Bell et al.

    Lymphatic invasion in pigmented nevi

    Am J Clin Pathol

    (1979)
  • C. Callery et al.

    Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph node

    Ann Surg

    (1982)
  • CarsonK.F. et al.

    Nodal nevi and cutaneous melanoma

    Am J Surg Pathol

    (1996)
  • A.J. Cochran

    Surgical pathology remains pivotal in the evaluation of sentinel lymph nodes

    Am J Surg Pathol

    (1999)
  • A.J. Cochran et al.

    Melanocytic Tumors: A Guide to Diagnosis

  • CochranA.J. et al.

    Histomorphometry in the assessment of prognosis in Stage II malignant melanoma

    Am J Surg Pathol

    (1989)
  • Cochran AJ, Morton DL, Stern S, et al: Sentinel nodes show profound down regulation of antigen-presenting cells of the...
  • A.J. Cochran et al.

    Variations in the reactivity of individual regional lymph nodes draining malignant melanoma: Histologic and immunohistologic studies

    J Natl Cancer Inst

    (1987)
  • CochranA.J. et al.

    Occult tumor cells in the lymph nodes of patients with pathological Stage I malignant melanoma

    Am J Surg Pathol

    (1988)
  • CochranA.J. et al.

    Immunosuppression by melanoma cells as a factor in the generation of metastatic disease

    Anticancer Res

    (1989)
  • P.S. Dale et al.

    Metastasis of melanoma to two separate lymph node basins: Prognostic significance

    Ann Surg Oncol

    (1997)
  • Z. Farzad et al.

    Phenotypic changes in lymphocytes of lymph nodes draining human cutaneous melanoma

    Cancer Res

    (1990)
  • A.E. Giuliano et al.

    Clinical aspects of unknown primary melanoma

    Ann Surg

    (1981)
  • Cited by (16)

    • The role of sentinel lymph node biopsy for melanoma

      2002, Seminars in Oncology
      Citation Excerpt :

      The overall rate of discordance was 20%. These results suggest that preoperative lymphoscintigraphy is a prerequisite for characterizing the lymphatic drainage pattern in patients with primary melanoma, especially for sites such as the head, neck, and trunk, which frequently drain to multiple basins or multiple SLNs via aberrant pathways.23,50,51 The accuracy of preoperative lymphoscintigraphy has also been demonstrated.

    • Sentinel lymph node biopsy in melanoma patients

      2010, Journal of the European Academy of Dermatology and Venereology
    View all citing articles on Scopus

    Address reprint requests to Alistair J. Cochran, MD, FRCP, UCLA School of Medicine, Department of Pathology and Laboratory Medicine, Box 951713, Los Angeles, CA 90095-1713, e-mail: [email protected]

    *

    Department of Pathology and Laboratory Medicine, University of California Los Angeles School of Medicine, Los Angeles, California

    View full text